P

Prokarium

24 employees

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Biotechnology
Synthetic Biology
Vaccines
Oral delivery
Health Care
Microbial Immunotherapy
Oncology
Immunotherapy
Immunology
Salmonella
Genetics

Date founded

2012

Funding rounds raised

Total raised

$30M

from 12 investors over 12 rounds

P

Prokarium raised $30M on February 9, 2023

Investors: Flerie Invest

P

Prokarium raised $21M on October 27, 2020

Investors: Korea Investment Partners, Flerie Invest and Riyadh Valley Company (RVC)

P

Prokarium raised $5.6M on October 8, 2019

Investors: Wellcome Trust

P

Prokarium raised $10M on February 26, 2018

Investors: Korea Investment Partners, Flerie Invest and Riyadh Valley Company (RVC)

P

Prokarium raised undisclosed on August 3, 2015

Investors: SynbiCITE

P

Prokarium raised $595K on March 11, 2013

Investors: BBSRC and Innovate UK

P

Prokarium raised $8M on January 1, 2012

Investors: Flerie Invest

FAQ